The White House wants to see the market impact of producing a new generation of COVID-19 vaccines on the Nucleic Acid purification system
The White House wants to speed up the development of a new generation of COVID-19 vaccines, Statistics News reported Monday. Ideally, future vaccines will provide longer-lasting protection against viral infection and transmission, not just severe illness and death.
Federal officials, researchers and representatives from pharmaceutical companies Pfizer and Moderna will hold a "summit" at the White House Tuesday to discuss the next steps. It is unclear whether President Biden, who is currently infected with COVID-19, will attend.
Currently available COVID-19 vaccines are still very good at preventing most people from becoming seriously ill or dying from COVID-19. But the proliferation of new variants of the virus - the recent emergence of various forms of the Omicron variant - has undermined the effectiveness of vaccines to prevent infection and milder diseases. In the near term, pharmaceutical companies and the Food and Drug Administration are working to develop the latest vaccine boosters against Omicron.
But experts say chasing variation is not the best or most sustainable way to develop a vaccine. Ashish Jha, the White House COVID-19 response coordinator, told Stat News that the White House is working on two approaches to next-generation vaccines. The first is a nasal spray vaccine that creates an immune response and blocks the virus as it enters the body. The second approach is to create a vaccine that targets parts of the virus that are shared between the mutated viruses, and that will remain more effective even as the virus continues to mutate. Both will be daunting scientific challenges -- the nasal-sprayed COVID-19 vaccine is still experimental, and vaccine developers have been working for years to create a universal flu vaccine.
Getting the investment needed to drive the next batch of vaccines will be another challenge. The White House is already trying to find funding for COVID-19 response efforts, including vaccines. Republican lawmakers have blocked efforts to provide more COVID-19 aid money, and Democratic leadership is struggling to figure out a way forward.
Without new vaccination methods, public health efforts could stall, unable to keep up with the virus -- which still kills more than 400 people a day in the United States.
"The virus is constantly evolving," Jha told Stat News. "We have to move with The Times, and that's fine. But in the long term, we really need a major breakthrough."
Overview of market area prospect of Nucleic Acid purification system
By region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa (MEA). North America is further divided into countries such as the United States and Canada. The European region is further divided into The United Kingdom, France, Germany, Italy, Spain, Russia and the rest of Europe. The Asia Pacific region is further subdivided into China, Japan, Korea, India, Australia, Southeast Asia and the rest of Asia Pacific. The Latin America region is further subdivided into Brazil, Mexico and the rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa and the rest of MEA.
Buy high quality and effective DNA & RNA nucleic acid extraction reagent, lab consumables, automatic nucleic acid extractions, real-time PCR equipment and consumables or Nucleic Acid purification system . Send an email to: email@example.com and our professional sales engineer will get back to you within 48 hours.
Analysis and forecast of the market size of PCR diagnostic industry
Polymerase chain reaction (PCR) is a nucleic acid synthesis technology that uses the principle of DNA double-strand replication to replicate specific DNA fragments in vitro. With this technology, the detection equipment can amplify the target gene in a large number in a short time, expanding the target gene fragment to the order of millions to billions, thus achieving high sensitivity detection. At present, polymerase chain reaction (PCR) diagnosis of infectious diseases such as hepatitis, venereal disease, intestinal respiratory disease and tumor single gene detection is an important application field. In 2020, polymerase chain reaction (PCR) diagnostic technology was identified as the "gold standard" for COVID-19 diagnosis due to its high sensitivity and accuracy.
China's PCR diagnostic market is developing rapidly, with the market size growing rapidly from about RMB 2.37 billion in 2015 to about RMB 5.93 billion in 2019, with a compound annual growth rate of 25.8%. China's PCR industry experienced explosive growth due to the huge demand for testing caused by the outbreak of COVID-19 in 2020, and the market size of China's PCR diagnostic industry exceeded 10 billion yuan in 2020. With the introduction of a large number of PCR diagnostic instruments, the PCR diagnostic industry will enter a new stage of development. It is expected that the PCR diagnostic industry will maintain a double-digit growth rate, and the market size of the PCR diagnostic industry will reach about 23.42 billion yuan in 2030 based on the factory price, and the cagR will reach about 13.3% from 2019 to 2030.
Market Demand of the Nucleic Acid purification system
The DNA/RNA Extraction Kit market and other Nucleic Acid purification system s are projected to grow at a CAGR of 8.26% during the forecast period 2022-2027.
The COVID-19 pandemic has impacted the Nucleic Acid purification system market for a short time due to restrictions on different business and research activities for Nucleic Acid purification system s. In addition, diagnostic tests for other diseases and medical conditions in hospitals and other clinical diagnostic facilities have been affected as COVID-19 has led to fewer patients taking tests. However, the high rate of COVID-19 infection and research activities are undertaken by major companies in the field of sequencing to expand their understanding of the virus and its origins, as well as molecular diagnostics of the SARS-COV-2 virus, have led to the development and launch of many DNA - and RNA-BASED COVID-19 kits, The kits proved so important that they were in great demand.
Market drivers for the Nucleic Acid purification system
The growth of the DNA/RNA extraction kit market is primarily driven by increased investment in R&D activities in different areas, including molecular diagnostics for different chronic and infectious diseases. For example, the US spent $842 billion on R&D activities in 2020, followed by China at $664 billion, according to the ORGANISATION for Economic Co-operation and Development. Technological advances worldwide, new product launches by major market players, and an increase in cancer cases are also likely to complement the growth of the markets under study.
Other factors, such as increased demand for automation of DNA/RNA extraction technologies, new user-friendly and easy extraction kits, and DNA/RNA for analysis of new diseases causing microorganisms, are expected to drive DNA/RNA growth. RNA Extraction Kit market during the forecast period. Therefore, low awareness and availability of the kit and low market penetration in less developed and developing regions around the world are the major factors limiting the growth of the DNA/RNA extraction kit market.
North America is expected to dominate the global Nucleic Acid purification system market during the forecast period
North America, which holds a major share in the Nucleic Acid purification system market, is expected to show a similar trend during the forecast period, mainly due to the high level of R&D activity in the region and the presence of major market players in the region constantly developing their products for the markets studied.
In the region, the US is expected to take a major share of the DNA/RNA extraction kit market due to heavy investment in R&D by government and private entities, increased demand for Nucleic Acid purification system s, and the rising prevalence of chronic diseases.
The Nucleic Acid purification system professional supplier manufacturer -Geneture
Geneture is a professional supplier of Nucleic Acid Extraction Reagent,Automatic Nucleic Acid Extraction,Lab consumables, Real-time PCR, Covid-19 Rapid Test Supplier. Buy high quality and effective DNA & RNA nucleic acid extraction reagent, lab consumables, automatic nucleic acid extractions, real-time PCR equipment and consumables.
Silicon nitride ceramic is a kind of synthetic material with strong covalent bond force between silicon and nitrogen atoms in its structure, so it has the characteristics of high strength, high hardness, corrosion resistance, oxidation resistance, we…
The commonly used superplasticizers include polycarboxylate series, naphthalene series, fatty acid series, and other superplasticizers.…
Russian President says if the European Union imposes an oil embargo, Europe will buy energy at the most expensive price and economic activity in Europe will weaken. Rosneft needs to change its business model. Russia will help facilitate settlement an…